Cartiva Treats First US Patient in Thumb OA Study

The first U.S. patient has been treated in GRIP 2, a multi-center study evaluating Cartiva's Synthetic Cartilage Implant (SCI) to treat first carpometacarpal (CMC) joint osteoarthritis at the base of the thumb.

GRIP 2 is comparing SCI to a ligament reconstruction tendon interposition comparator in an estimated 74 patients in the U.S. and...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us